Privia Health Group (PRVA) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Privia Health Group

NasdaqGS•Healthcare•Health Information Services

$20.37+0.01(<0.01%)Pre-market

Market Cap

$2.53B

P/E

90.1x

P/S

1.1x

P/B

3.2x

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

How this company scores

GoodMetricSide Score: 68/100

Strongest: Cash & Earnings Quality (23/25); weakest: Profitability (8/25).

Profitability8/25

Growth22/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality23/25

Strengths

Growing revenueRising free cash flowRising earningsInterest easily covered

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 90.1x5y range 71.1x – 194.3x

Currently below its 14-quarter median.

P/S · 1.1x5y range 1.1x – 3.0x

Currently below its 19-quarter median.

P/B · 3.2x5y range 3.2x – 8.1x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Cash Burn

Watch

FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.

Price & Volume

Market Cap $2.53B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.36B
Q. Revenue: $632.63M
TTM EBITDA: $56.94M
TTM Op. Income: $44.88M
Q. Op. Income: $11.77M
TTM Net Income: $28.12M
Q. Net Income: $9.05M
EPS: $0.07
Shares Out.: $126.12M

$2.36B in TTM revenue grew 24.1% YoY, reaching $632.63M last quarter. TTM EBITDA of $56.94M and TTM operating income of $44.88M show growth is flowing through to the bottom line. TTM net income of $28.12M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 2.4%
Op. Margin: 1.9%
Net Margin: 1.4%

Op. margin of 1.9% is up 1.2% YoY — cost efficiency is improving. Net margin at 1.4% Over the past year, operating margin is up 191% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 90.1x
P/S Ratio: 1.1x
P/B Ratio: 3.2x

At 90.1x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 1.1x and P/B of 3.2x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 4 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.49B
Cash: $412.20M
Long-Term Debt: N/A
Book Value: $782.33M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $1.10M
TTM Free Cash Flow: $131.13M
FCF Margin: 5.6%
FCF / Net Income: 4.7

TTM FCF of $131.13M on $1.10M in operating cash flow. The FCF / Net Income ratio of 4.7x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.